solutions Epionce Active Shield Lotion Generic Name: homosalate, zinc oxide, octisalate Dosage Form: lotion Print this page Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies. Active Ingredients Homosalate 10.0% Zinc Oxide 9.2% Octisalate 5.0% Purpose Sunscreen Warnings For external use only Do not use on damaged or broken skin Stop use and ask a doctor if rash occurs When using this product keep out of eyes. Rinse with water to remove. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away. Directions • helps prevent sunburn apply liberally 15 minutes before sun exposure • use a water resistant sunscreen if swimming or sweating • reapply at least every 2 hours • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m.- 2 p.m. • wear long-sleeved shirts, pants, hats and sunglasses Ask a doctor children under 6 months Inactive Ingredients Water, Alkyl (C12-15) Benzoate, Butylene Glycol, Glycerin, Steareth-21, Phenyl Trimethicone, Meadowfoam Seed Oil, Cetostearyl Alcohol, Safflower Oil, Ammonium Acryloyldimethyltaurate/VP Copolymer, Caprylyl Glycol, Ethylhexylglycerin, Hexylene Glycol, Linseed Oil, Malic Acid, Phenoxyethanol, Date, Polyhydroxystearic Acid (2300 MW), Steareth-2, Triethoxycaprylylsilane, Pyrithione Zinc. Other Information • protect this product from excessive heat and direct sun Questions? Call toll free 1-800-374-6623 Drug Facts EPIONCE ACTIVE SHIELD SPF 30 homosalate, zinc oxide, octisalate lotion Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:42673-002 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HOMOSALATE (HOMOSALATE) HOMOSALATE 0.10 mL in 1 mL ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 0.92 mL in 1 mL OCTISALATE (OCTISALATE) OCTISALATE 0.05 mL in 1 mL Inactive Ingredients Ingredient Name Strength AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER BUTYLENE GLYCOL ALKYL (C12-15) BENZOATE CAPRYLYL GLYCOL SAFFLOWER OIL CETOSTEARYL ALCOHOL ETHYLHEXYLGLYCERIN GLYCERIN HEXYLENE GLYCOL MEADOWFOAM SEED OIL LINSEED OIL MALIC ACID PHENOXYETHANOL PHENYL TRIMETHICONE DATE POLYHYDROXYSTEARIC ACID (2300 MW) STEARETH-2 STEARETH-21 TRIETHOXYCAPRYLYLSILANE WATER PYRITHIONE ZINC Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:42673-002-02 1 TUBE in 1 BOX 1 NDC:42673-002-01 75 mL in 1 TUBE 2 NDC:42673-002-04 453 mL in 1 JAR 3 NDC:42673-002-03 6 mL in 1 TUBE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part352 03/24/2005 Labeler - Episciences, Inc. (144733040) Registrant - Episciences, Inc. (144733040) Establishment Name Address ID/FEI Operations Episciences, Inc. 144733040 manufacture(42673-002) Revised: 08/2012 Episciences, Inc. FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More most luxurious
there isn't Epionce Active Shield Lotion a petroleum
EmoticonEmoticon